We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
-8.61%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$369M
AUM Growth
-$30.4M
Cap. Flow
+$16.8M
Cap. Flow %
4.54%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$16.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$179M 48.51%
19,963,157
+1,839,265
+10% +$16.8M
AURA icon
2
Aura Biosciences
AURA
$725M
$66.9M 18.12%
3,039,892
– –
PCVX icon
3
Vaxcyte
PCVX
$7.81B
$45.6M 12.35%
1,887,478
– –
MRUS
4
DELISTED
Merus
MRUS
$42.3M 11.46%
1,600,000
– –
PHAT icon
5
Phathom Pharmaceuticals
PHAT
$708M
$28.1M 7.62%
2,067,861
– –
CMPI
6
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$4.79M 1.3%
1,501,716
– –
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.37M 0.64%
1,570,000
– –

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Medicxi Ventures Management's Q1 2022 Portfolio in Review

As of Q1 2022, Medicxi Ventures Management held 7 positions worth $369M, down 7.6% from $400M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Medicxi Ventures Management deployed $16.8M of net new capital in Q1 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management added most to Centessa Pharmaceuticals in Q1 2022, an estimated $16.8M increase.
  • Medicxi Ventures Management's ten largest holdings make up 100% of its $369M portfolio in Q1 2022.
  • Medicxi Ventures Management opened 0 new positions and closed 0 in Q1 2022.
  • Medicxi Ventures Management's portfolio value fell 7.6% quarter-over-quarter to $369M.

Based on Medicxi Ventures Management's 13F filing for Q1 2022, filed 12 May 2022.